Institute of Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wasserturmstr. 3-5, 91054 Erlangen, Germany.
Pediatric Gastroenterology, Hepatology and Endoscopy, Department of Pediatrics and Adolescent Medicine, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestr. 15, 91054 Erlangen, Germany.
J Leukoc Biol. 2023 Jun 1;113(6):615-625. doi: 10.1093/jleuko/qiad029.
TNF blockade constitutes an effective therapy for inflammatory bowel disease, yet increases the risk for infection, including active tuberculosis. The DECTIN2 family C-type lectin receptors MINCLE, MCL, and DECTIN2 sense mycobacterial ligands and activate myeloid cells. In mice, upregulation of DECTIN2 family C-type lectin receptor after stimulation with Mycobacterium bovis Bacille Calmette-Guérin requires TNF. Here, we investigated whether TNF controls inducible C-type lectin receptor expression in human myeloid cells. Monocyte-derived macrophages were stimulated with Bacille Calmette-Guérin and the TLR4 ligand lipopolysaccharide, and expression of C-type lectin receptor was analyzed. Bacille Calmette-Guérin and lipopolysaccharide strongly upregulated messenger RNA expression of DECTIN2 family C-type lectin receptor but not of DECTIN1. Bacille Calmette-Guérin and lipopolysaccharide also induced robust production of TNF. Recombinant TNF was sufficient to upregulate expression of DECTIN2 family C-type lectin receptor. Blocking TNF with the TNFR2-Fc fusion protein etanercept abrogated, as expected, the effect of recombinant TNF and impaired induction of DECTIN2 family C-type lectin receptor by Bacille Calmette-Guérin and lipopolysaccharide. Flow cytometry confirmed upregulation of MCL at the protein level by recombinant TNF and showed inhibition of Bacille Calmette-Guérin-induced MCL by etanercept. To investigate the impact of TNF on C-type lectin receptor expression in vivo, we analyzed peripheral blood mononuclear cells of patients with inflammatory bowel disease and observed downregulation of MINCLE and MCL expression after therapeutic TNF blockade. Together, TNF is sufficient to upregulate DECTIN2 family C-type lectin receptor in human myeloid cells and contributes to this process after encounter with Bacille Calmette-Guérin or lipopolysaccharide. Impaired C-type lectin receptor expression in patients receiving TNF blockade may dampen the sensing of microbes and defense against infection.
TNF 阻断剂构成了一种有效的炎症性肠病治疗方法,但会增加感染的风险,包括活动性肺结核。DECTIN2 家族 C 型凝集素受体 MINCLE、MCL 和 DECTIN2 可感知分枝杆菌配体并激活髓样细胞。在小鼠中,经牛分枝杆菌卡介苗刺激后,DECTIN2 家族 C 型凝集素受体的上调需要 TNF。在这里,我们研究了 TNF 是否控制人类髓样细胞中诱导型 C 型凝集素受体的表达。用卡介苗和 TLR4 配体脂多糖刺激单核细胞衍生的巨噬细胞,并分析 C 型凝集素受体的表达。卡介苗和脂多糖强烈地上调了 DECTIN2 家族 C 型凝集素受体的信使 RNA 表达,但不影响 DECTIN1。卡介苗和脂多糖也诱导了 TNF 的大量产生。重组 TNF 足以上调 DECTIN2 家族 C 型凝集素受体的表达。用 TNFR2-Fc 融合蛋白依那西普阻断 TNF,如预期的那样,阻断了重组 TNF 的作用,并损害了卡介苗和脂多糖诱导的 DECTIN2 家族 C 型凝集素受体的诱导。流式细胞术证实了重组 TNF 在蛋白质水平上上调了 MCL,并显示了依那西普对卡介苗诱导的 MCL 的抑制作用。为了研究 TNF 对体内 C 型凝集素受体表达的影响,我们分析了炎症性肠病患者的外周血单核细胞,观察到在接受 TNF 阻断治疗后 MINCLE 和 MCL 的表达下调。总之,TNF 足以上调人髓样细胞中的 DECTIN2 家族 C 型凝集素受体,并有助于在遇到卡介苗或脂多糖后促进该过程。接受 TNF 阻断治疗的患者的 C 型凝集素受体表达受损可能会抑制对微生物的感知和对感染的防御。